Employer / Commercial Insurance
Covered with requirementsWhat you need to qualify
- Diagnosis documented with a code
- Lab results confirming eligibility
Qualification pathways
You can qualify through any one of these.
Type 2 Diabetes
All of:
- Diagnosis of Type 2 diabetes confirmed with lab testing
- No concurrent use of other GLP-1 receptor agonists
- Not using for weight loss or other excluded diagnosis
- Not in diabetes remission (HbA1c < 6.5% for at least 3 months without glucose-lowering therapy)
Documentation to bring
- Lab confirmation of Type 2 diabetes diagnosis
- Claims history and ICD-10 codes reviewed
- Documentation that patient is not using concurrently with another GLP-1 receptor agonist
Approval and renewal
- Initial approval: 24 months
- Renewal: every 24 months
- To renew, the plan looks for Documentation of disease responsiveness to therapy required at reauthorization.
Not covered when
- Use for weight loss or other excluded diagnosis
- Dosing above FDA-approved label for treatment of diabetes
- Diabetes remission (HbA1c < 6.5% persisting ≥3 months without usual glucose-lowering therapy)
- History of ketoacidosis
- Concurrent use of other GLP-1 receptor agonists
Policy note: Mounjaro is FDA-approved for T2DM. Policy covers all FDA-approved indications not otherwise excluded. Authorization duration is 24 months unless otherwise specified.
Policy effective June 22, 2026 · verified June 10, 2026 · source: cw577pv8jf